Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

被引:134
|
作者
Foray, N
Randrianarison, V
Marot, D
Perricaudet, M
Lenoir, G
Feunteun, J
机构
[1] Inst Gustave Roussy, CNRS UMR 1599, Lab Genet Oncol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CNRS UMR 1582, Lab Vectorol & Transfert Genes, F-94805 Villejuif, France
[3] Univ Lyon 1, CNRS UMR 5641, Lab Genet & Canc, F-69365 Lyon, France
关键词
BRCA1; BRCA2; DNA repair; radiation;
D O I
10.1038/sj.onc.1203165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is now evidence to suggest that BRCA1 and BRCA2 are involved in the response of cells to DNA damage and cell cycle checkpoint control. This report examines the death pathways of human cells with various BRCA1 and BRCA2 genotypes after exposure to gamma-rays, A lack of functional BRCA1 and BRCA2 led to defective repair of DNA double-strand breaks in irradiated cells. This impairment resulted in a relaxation of cell cycle checkpoints, production of micronuclei, and a loss of proliferative capacity, Heterozygous BRCA1 and BRCA2 mutations also led to enhanced radiosensitivity, with an impaired proliferative capacity after irradiation. The existence of a phenotype related to radiosensitivity in BRCA1(+/-) and BRCA2(+/-) cells raises the question of the response of heterozygous women to radiation.
引用
收藏
页码:7334 / 7342
页数:9
相关论文
共 50 条
  • [31] BRCA1 and BRCA2 mutations and the risk for colorectal cancer
    Sopik, V.
    Phelan, C.
    Cybulski, C.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 87 (05) : 411 - 418
  • [32] BRCA1 and BRCA2 germline mutations in lymphoma patients
    Yossepowitch, O
    Olvera, N
    Satagopan, JM
    Huang, H
    Jhanwar, S
    Rapaport, B
    Boyd, J
    Offit, K
    LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 127 - 131
  • [33] Bone loss in women with BRCA1 and BRCA2 mutations
    Powell, C. Bethan
    Alabaster, Amy
    Stoller, Nicole
    Armstrong, Mary Anne
    Salyer, Chelsea
    Hamilton, Isabella
    Raine-Bennett, Tina
    GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 535 - 539
  • [34] Cancer treatment according to BRCA1 and BRCA2 mutations
    Maxwell, Kara N.
    Domchek, Susan M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (09) : 520 - 528
  • [35] Cancer treatment according to BRCA1 and BRCA2 mutations
    Kara N. Maxwell
    Susan M. Domchek
    Nature Reviews Clinical Oncology, 2012, 9 : 520 - 528
  • [36] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261
  • [37] Relevant risk for women with BRCA1 and BRCA2 mutations
    Furnival, Colin
    ANZ JOURNAL OF SURGERY, 2007, 77 (05) : 309 - 309
  • [38] BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations
    Ahn, Sei Hyun
    Son, Byung Ho
    Yoon, Kyung-Sik
    Noh, Dong-Young
    Han, Wonshik
    Kim, Sung-Won
    Lee, Eun Sook
    Park, Hai-Lin
    Hong, Young Joon
    Choi, Jae Jin
    Moon, Seo Yun
    Kim, Mi Jeong
    Kim, Kye Hyun
    Kwak, Beom Seok
    Cho, Dae-Yeon
    CANCER LETTERS, 2007, 245 (1-2) : 90 - 95
  • [39] Evidence for accelerated aging in mammary epithelia of women carrying germline BRCA1 or BRCA2 mutations
    Shalabi, Sundus F.
    Miyano, Masaru
    Sayaman, Rosalyn W.
    Lopez, Jennifer C.
    Jokela, Tiina A.
    Todhunter, Michael E.
    Hinz, Stefan
    Garbe, James C.
    Stampfer, Martha R.
    Kessenbrock, Kai
    Seewaldt, Victoria E.
    LaBarge, Mark A.
    NATURE AGING, 2021, 1 (09): : 838 - +
  • [40] LIPID AND METABOLITE DEREGULATION IN THE BREAST TISSUE OF WOMEN CARRYING BRCA1 AND BRCA2 GENETIC MUTATIONS
    Ramadan, Saadallah
    Arm, Jameen
    Silcock, Judith
    Santamaria, Gorane
    Buck, Jessica
    Roy, Michele
    Leong, Kin Men
    Lau, Peter
    Clark, David
    Malycha, Peter
    Mountford, Carolyn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 1 - 1